Search for: "SMITH v. A-C PRODUCT LIABILITY TRUST"
Results 21 - 40
of 56
Sorted by Relevance
|
Sort by Date
2 Feb 2010, 7:28 am
App. 1979) (label change); Smith v. [read post]
24 Feb 2023, 1:27 pm
Smith v. [read post]
4 Mar 2019, 10:55 am
| The Opinion of the Advocate General in the case C-443/17 (Abraxis case). [read post]
2 Mar 2010, 4:04 pm
Simpson v Vale of Aylesbury Care Trust. [read post]
2 Jun 2011, 12:46 pm
Appx. 446 (6th Cir. 2010); Smith v. [read post]
14 Nov 2013, 1:04 pm
Simon.Stahl, Philip Michael.Chicago, Illinois : ABA Section of Family Law, [2013]KF547 .S733 2013 Family Law According to our hearts : Rhinelander v. [read post]
29 Dec 2008, 9:53 pm
They believe it makes the product less safe and less nutritious and wouldn’t touch it with a 10-foot pole. [read post]
23 Jun 2014, 12:57 pm
Sox, Michael C. [read post]
28 Jun 2007, 10:16 am
Did the product not work? [read post]
15 Jan 2009, 5:14 am
Over at the FDA Blog they can draw on a whole firm of FDA specialists; and Reed Smith's got 150 potential blog contributors in their health/products group. [read post]
7 Feb 2008, 10:46 am
In a brave, new preemption world, such things might amount to breaches in the dike preventing liability. [read post]
19 Mar 2022, 2:09 pm
The agency assessing risk may decide to bar a substance or product if the potential benefits are outweighed by the possibility of risks that are largely unquantifiable because of presently unknown contingencies. [read post]
8 Mar 2021, 4:17 pm
SVI TRUST, Appellant, v. [read post]
10 Apr 2019, 9:11 am
Lemon: different issue when service markets physical product Smith: is that different from generating eyeballs for ads? [read post]
24 Jul 2011, 2:38 pm
(Zelig v. [read post]
18 Jul 2009, 7:31 am
C. [read post]
25 Jul 2022, 1:54 am
Keith Enright explained that the CBPR system as “an important step toward enabling continued, trusted data flows between participating jurisdictions. [read post]
4 Jul 2010, 6:02 pm
RPS Products, Inc. [read post]
6 Sep 2021, 5:27 am
BER-C-54-21FILEDJUL 12 2021 James J. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
